샘플 요청 목록

 카트 문의
시장보고서
상품코드
1588912

세계의 단일 세포 게놈 시퀀싱 시장

Single-Cell Genome Sequencing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 89 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

단일세포 게놈 시퀀싱 세계 시장은 2030년까지 72억 달러에 달할 전망입니다.

2023년에 29억 달러로 추정되는 단일 세포 게놈 시퀀싱 세계 시장은 분석 기간 2023-2030년에 CAGR 13.6%로 성장하여 2030년에는 72억 달러에 이를 것으로 예측됩니다. 분석한 부문 중 하나인 세포 게놈 시퀀싱 장비는 CAGR 14.2%로 성장을 지속하고, 분석 기간이 끝나면 45억 달러에 도달할 것으로 예측됩니다.

미국 시장은 8억 350만 달러로 추정, 중국은 CAGR 12.8%로 성장할 것으로 예측

미국의 단일 세포 게놈 시퀀싱 시장은 2023년 8억 350만 달러로 추정됩니다. 분석 기간(2023-2030년)중 CAGR는 12.8%로 예상됩니다.입니다. 기타 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 11.9%와 11.4%로 예측되고 있습니다.

세계의 단일 세포 게놈 시퀀싱 시장 - 주요 동향과 촉진요인 요약

단일 세포 게놈 시퀀싱는 유전체 조사를 어떻게 진행하고 있는가?

단일 세포 게놈 시퀀싱는 과학자가 개별 세포의 유전 물질을 분석 할 수있게 해주는 최첨단 기술이며, 세포의 이질성, 유전자 발현 및 질병 메커니즘에 대한 통찰력을 입자 크기 수준으로 제공 이 기술은 암의 진행, 면역 반응, 신경 질환, 발생 생물학 등의 복잡한 생물학적 시스템을 이해하는데 매우 중요합니다. 연구자들이 조직 내 유전적 돌연변이와 세포의 다양성을 확인할 수 있게 함으로써 단일 세포 게놈 시퀀싱은 질병 경로에 대한 보다 깊은 이해를 제공하고 보다 효과적인 진단, 표적 치료, 맞춤형 의료 접근으로 이어집니다. 정밀의료에 대한 수요가 높아지는 가운데, 단일 세포 게놈 시퀀싱는 유전체학 연구와 임상 응용에 혁명을 일으키고 있습니다.

단일 세포 게놈 시퀀싱 시장의 주요 부문은?

주요 기술로는 마이크로플루이딕스, 차세대 시퀀서(NGS), 정량 PCR 등이 있으며, 차세대 시퀀서는 높은 처리량, 정밀도, 종합적인 데이터 출력으로 최대 시장 점유율을 차지합니다. 용도는 암 유전체, 면역학, 줄기 세포 연구, 신경 생물학, 암 유전체학은 단일 세포 시퀀싱에 의해 종양 불균일성과 약물 내성에 대한 중요한 지식을 얻을 수 있기 때문에 중요한 부문을 차지하고 있습니다. 연구기관은 유전적 변이와 세포의 다양성 탐색에 중점을 두고 있기 때문에 시장을 주요 기업으로 삼고 있습니다.

단일 세포 게놈 시퀀싱는 연구 및 의료 분야에서 어떻게 사용됩니까?

암 연구에서 단일 세포 게놈 시퀀싱는 유전자 변이, 종양의 진화, 약물 내성 메커니즘의 동정에 사용되며, 표적 요법과 맞춤형 치료 전략의 개발을 지원하고 있습니다. 이를 이용하여 면역세포의 다양성을 이해하고, 면역반응을 추적하고, 자가면역질환이나 백신 개발을 위한 바이오마커를 확인하고 있습니다. 계통 추적, 재생 가능성 분석 및 조직 공학 및 재생 의학의 진보에 도움이 됩니다 신경 생물학에서 단일 셀 시퀀싱는 신경 발달 장애의 유전적 기반, 시냅스 기능, 뉴런의 다양성에 대한 통찰력을 얻을 수 있으며, 알츠하이머 병과 자폐증과 같은 질병에 대한 더 깊은 이해에 기여하고 있습니다. 또한, 단일 세포 시퀀싱의 임상 응용은 특히 정확한 유전자 프로파일 링이 중요한 출생 전 진단과 희귀질환의 특정에 확대되고 있습니다.

단일 세포 게놈 시퀀싱 시장의 성장을 가속하는 요인은?

단일 세포 게놈 시퀀싱 시장의 성장은 맞춤형 치료를 개발하기 위해 세포 수준의 상세한 유전자 정보에 의존하는 정밀의료에 대한 수요 증가와 같은 여러 요인에 의해 견인되고 있습니다., 정 학위 향상, 비용 절감과 같은 시퀀싱 기술의 발전으로 단일 세포 시퀀싱이 연구 및 임상 분야에서보다 쉽게 활용되고 있습니다. 포의 불균일성과 질병 메커니즘에 대한 통찰력을 얻을 수 있기 때문에 단일 세포 게놈 시퀀싱의 채용이 가속화되고 있습니다. 증가 이와 함께 시장의 성장을 더욱 촉진하고 있으며, 데이터 분석에 있어서 AI와 바이오인포매틱스의 통합은 복잡한 시퀀싱 데이터의 해석을 강화하고 유전체학 연구에 있어서 폭넓은 응용을 지원하고 있습니다.

조사 대상 기업 예(주목의 33사)

  • 10x Genomics
  • Agilent Technologies, Inc.
  • BGI
  • Bio-Rad Laboratories
  • DNA Electronics Ltd.
  • F Hoffmann-La Roche Ltd.
  • Fluidigm
  • Illumina, Inc.
  • Johnson & Johnson
  • Novogene
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Zephyrus Biosciences Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

JHS 24.11.22

Global Single-Cell Genome Sequencing Market to Reach US$7.2 Billion by 2030

The global market for Single-Cell Genome Sequencing estimated at US$2.9 Billion in the year 2023, is expected to reach US$7.2 Billion by 2030, growing at a CAGR of 13.6% over the analysis period 2023-2030. Cell Genome Sequencing Instruments, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$4.5 Billion by the end of the analysis period. Growth in the Cell Genome Sequencing Reagents segment is estimated at 12.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$803.5 Million While China is Forecast to Grow at 12.8% CAGR

The Single-Cell Genome Sequencing market in the U.S. is estimated at US$803.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 11.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Global Single-Cell Genome Sequencing Market - Key Trends and Drivers Summarized

How Is Single-Cell Genome Sequencing Advancing Genomics Research?

Single-cell genome sequencing is a cutting-edge technique that allows scientists to analyze the genetic material of individual cells, providing insights into cellular heterogeneity, gene expression, and disease mechanisms at a granular level. This technology is pivotal in understanding complex biological systems, including cancer progression, immune responses, neurological disorders, and developmental biology. By enabling researchers to identify genetic variations and cellular diversity within tissues, single-cell genome sequencing offers a deeper understanding of disease pathways, leading to more effective diagnostics, targeted therapies, and personalized medicine approaches. As the demand for precision medicine grows, single-cell genome sequencing continues to revolutionize genomics research and clinical applications.

What Are the Key Segments in the Single-Cell Genome Sequencing Market?

Key technologies include microfluidics, next-generation sequencing (NGS), and quantitative PCR, with next-generation sequencing holding the largest market share due to its high throughput, accuracy, and comprehensive data output. Major applications cover cancer genomics, immunology, stem cell research, and neurobiology, with cancer genomics representing a significant segment as single-cell sequencing provides critical insights into tumor heterogeneity and drug resistance. End-users encompass research institutes, clinical laboratories, and pharmaceutical companies, with research institutes leading the market due to their focus on exploring genetic variations and cellular diversity.

How Is Single-Cell Genome Sequencing Being Used Across Research and Medicine?

In cancer research, single-cell genome sequencing is used to identify genetic mutations, tumor evolution, and drug resistance mechanisms, supporting the development of targeted therapies and personalized treatment strategies. Immunology studies leverage single-cell sequencing to understand immune cell diversity, track immune responses, and identify biomarkers for autoimmune diseases and vaccine development. Stem cell research uses this technology to analyze cell differentiation, lineage tracing, and regenerative potential, aiding in advancements in tissue engineering and regenerative medicine. In neurobiology, single-cell sequencing provides insights into the genetic basis of neurodevelopmental disorders, synaptic functions, and neuron diversity, contributing to a better understanding of diseases like Alzheimer's and autism. Additionally, clinical applications of single-cell sequencing are expanding, particularly in prenatal diagnostics and rare disease identification, where accurate genetic profiling is crucial.

What Factors Are Driving the Growth in the Single-Cell Genome Sequencing Market?

The growth in the Single-Cell Genome Sequencing market is driven by several factors, including increasing demand for precision medicine, which relies on detailed genetic information at the cellular level to develop personalized treatments. Advancements in sequencing technologies, such as higher throughput, improved accuracy, and cost reductions, have made single-cell sequencing more accessible across research and clinical settings. The expanding focus on cancer genomics, immunotherapy, and neurodegenerative disease research has accelerated the adoption of single-cell genome sequencing, as it provides insights into cellular heterogeneity and disease mechanisms. Government funding and initiatives supporting genomics research, combined with growing collaborations between research institutes and pharmaceutical companies, have further fueled market growth. Additionally, the integration of AI and bioinformatics in data analysis has enhanced the interpretation of complex sequencing data, supporting broader applications in genomics research.

Select Competitors (Total 33 Featured) -

  • 10x Genomics
  • Agilent Technologies, Inc.
  • BGI
  • Bio-Rad Laboratories
  • DNA Electronics Ltd.
  • F Hoffmann-La Roche Ltd.
  • Fluidigm
  • Illumina, Inc.
  • Johnson & Johnson
  • Novogene
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Zephyrus Biosciences Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Single-Cell Genome Sequencing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine and Genomics Research Spurs Growth in Single-Cell Genome Sequencing Market
    • Technological Advancements in Sequencing Accuracy, Speed, and Data Analysis Strengthen Business Case for Adoption
    • Growing Focus on Cancer Genomics, Immunology, and Rare Disease Research Expands Addressable Market
    • Increasing Adoption of Sequencing in Stem Cell Research, Neuroscience, and Developmental Biology Expands Market Opportunities
    • Technological Innovations in Library Preparation, Microfluidics, and Bioinformatics Propel Market Expansion
    • Rising Focus on Complying with Ethical Guidelines, Informed Consent, and Data Privacy Drives Demand for Single-Cell Sequencing
    • Growing Use of Single-Cell Sequencing in Drug Discovery, Tumor Heterogeneity Studies, and Biomarker Discovery Expands Market Potential
    • Rising Adoption of Sequencing in Non-Invasive Prenatal Testing, Liquid Biopsies, and Cell-Free DNA Analysis Expands Addressable Market
    • Technological Advancements in AI-Powered Genomics, Machine Learning Algorithms, and Cloud Sequencing Propel Market Growth
    • Increasing Focus on Integrating Single-Cell Sequencing with Multi-Omics, CRISPR, and Synthetic Biology Drives Adoption
    • Rising Demand for Sequencing in Infectious Disease Genomics, Microbiome Research, and Immune Profiling Strengthens Global Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Single-Cell Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Single-Cell Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic & Research Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Academic & Research Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Biotech & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Biotech & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Biotech & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for MDA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for MDA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for MDA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 37: World Single-Cell Genome Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • JAPAN
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • CHINA
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • EUROPE
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Single-Cell Genome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Single-Cell Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • FRANCE
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • GERMANY
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Single-Cell Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제